In yet another indication of a globally stressed economy, and in yet another setback to embryonic stem cell research, the state of California has announced that it must delay the distribution of nearly $60 million in stem cell grant money.
Doctors in Chicago use adult stem cells derived from bone marrow to halt and reverse the progression of multiple sclerosis.
Nearly 5 years after the controversial Proposition 71 was voted into law, and with very little concrete progress to show for it, scientists are reevaluating the field of embryonic stem cell research in California.
The company Neuralstem has been awarded a patent for its proprietary technology to immortalize human neural stem cells.
The biotech company Geron has received FDA approval to conduct the first human clinical trial with embryonic stem cells.
Opexa Therapeutics holds an informative briefing on both executive and scientific company news.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.
